Brain+ at Altenpflege
Brain+ showcased at Danish Dementia Days & Altenpflege in Germany Following the market introduction of the first commercial version of its digital dementia care product, CST Assistant, in Denmark in Q4 2022 and in Germany in Q2 2023, Brain+ has scaled its go-to-market activities. As an essential component, this includes attendance and product showcasing at […]
Second Sales Contract
Brain+ closes its second sales contract for CST Therapist Companion with a dementia care center in Gladsaxe municipality Brain+ announces to have closed a second sales contract for the company’s new digital dementia product, CST – Therapist Companion. The sales contract is a 3-year contract, giving therapists in the municipal dementia care facility, Bakkegården demensboliger, in Gladsaxe access […]
New Digital Health Strategy in Germany
Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market This month the German Ministry of Health’s shared its new healthcare digitalization strategy, “Gemeinsam Digital”, together with a vision for an integrated digital health ecosystem in Germany. The country’s strong focus on digital solutions represents a great opportunity for Brain+ and other suppliers of digital therapeutics by enabling easier […]
EU GRANT
Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to an international research consortium consisting of the University of York Europe Campus, Greece, University of Gothenburg, Sweden, Brain+ A/S, Denmark, […]
New Cochrane review confirms CST
New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), has been published. The systematic review further strengthens the scientific evidence base of CST, the main therapy for dementia that […]
